Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0086 USD | +1.18% | +1.18% | -95.41% |
Mar. 05 | Akari Therapeutics, Plc entered into a definitive agreement to acquire Peak Bio, Inc.. | CI |
Feb. 16 | Peak Bio, Inc. announced that it has received $2.238 million in funding | CI |
- Stock Market
- Equities
- PKBO Stock
- News Peak Bio, Inc.
- Press Releases